161 related articles for article (PubMed ID: 15048994)
1. Proteomic analysis of cholangiocarcinoma cell line.
Srisomsap C; Sawangareetrakul P; Subhasitanont P; Panichakul T; Keeratichamroen S; Lirdprapamongkol K; Chokchaichamnankit D; Sirisinha S; Svasti J
Proteomics; 2004 Apr; 4(4):1135-44. PubMed ID: 15048994
[TBL] [Abstract][Full Text] [Related]
2. Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.
Srisomsap C; Sawangareetrakul P; Subhasitanont P; Chokchaichamnankit D; Chiablaem K; Bhudhisawasdi V; Wongkham S; Svasti J
J Biomed Biotechnol; 2010; 2010():437143. PubMed ID: 20069059
[TBL] [Abstract][Full Text] [Related]
3. Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Al-Bahrani R; Nagamori S; Leng R; Petryk A; Sergi C
Pathol Oncol Res; 2015 Sep; 21(4):901-8. PubMed ID: 25740074
[TBL] [Abstract][Full Text] [Related]
4. Comparison of membrane-associated proteins in human cholangiocarcinoma and hepatocellular carcinoma cell lines.
Srisomsap C; Subhasitanont P; Sawangareetrakul P; Chokchaichamnankit D; Ngiwsara L; Chiablaem K; Svasti J
Proteomics Clin Appl; 2007 Jan; 1(1):89-106. PubMed ID: 21136613
[TBL] [Abstract][Full Text] [Related]
5. Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker.
Verathamjamras C; Weeraphan C; Chokchaichamnankit D; Watcharatanyatip K; Subhasitanont P; Diskul-Na-Ayudthaya P; Mingkwan K; Luevisadpaibul V; Chutipongtanate S; Champattanachai V; Svasti J; Srisomsap C
Int J Oncol; 2017 Jul; 51(1):269-280. PubMed ID: 28560424
[TBL] [Abstract][Full Text] [Related]
6. A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.
Shi Y; Deng X; Zhan Q; Shen B; Jin X; Zhu Z; Chen H; Li H; Peng C
J Gastrointest Surg; 2013 Sep; 17(9):1584-91. PubMed ID: 23868055
[TBL] [Abstract][Full Text] [Related]
7. Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins.
Kim J; Kim SH; Lee SU; Ha GH; Kang DG; Ha NY; Ahn JS; Cho HY; Kang SJ; Lee YJ; Hong SC; Ha WS; Bae JM; Lee CW; Kim JW
Electrophoresis; 2002 Dec; 23(24):4142-56. PubMed ID: 12481271
[TBL] [Abstract][Full Text] [Related]
8. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
[TBL] [Abstract][Full Text] [Related]
9. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis.
Ding SJ; Li Y; Tan YX; Jiang MR; Tian B; Liu YK; Shao XX; Ye SL; Wu JR; Zeng R; Wang HY; Tang ZY; Xia QC
Mol Cell Proteomics; 2004 Jan; 3(1):73-81. PubMed ID: 14593079
[TBL] [Abstract][Full Text] [Related]
10. Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma.
Yonglitthipagon P; Pairojkul C; Bhudhisawasdi V; Mulvenna J; Loukas A; Sripa B
Clin Biochem; 2012 Jul; 45(10-11):827-34. PubMed ID: 22552009
[TBL] [Abstract][Full Text] [Related]
11. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
Lee JD; Yang WI; Park YN; Kim KS; Choi JS; Yun M; Ko D; Kim TS; Cho AE; Kim HM; Han KH; Im SS; Ahn YH; Choi CW; Park JH
J Nucl Med; 2005 Oct; 46(10):1753-9. PubMed ID: 16204727
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma.
Cirqueira CS; Felipe-Silva AS; Wakamatsu A; Marins LV; Rocha EC; de Mello ES; Alves VAF
Pathol Oncol Res; 2019 Oct; 25(4):1363-1371. PubMed ID: 29464551
[TBL] [Abstract][Full Text] [Related]
13. Strategic shotgun proteomics approach for efficient construction of an expression map of targeted protein families in hepatoma cell lines.
Lee CL; Hsiao HH; Lin CW; Wu SP; Huang SY; Wu CY; Wang AH; Khoo KH
Proteomics; 2003 Dec; 3(12):2472-86. PubMed ID: 14673797
[TBL] [Abstract][Full Text] [Related]
14. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
[TBL] [Abstract][Full Text] [Related]
15. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
[TBL] [Abstract][Full Text] [Related]
16. Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Yi X; Zhu J; Liu W; Peng L; Lu C; Sun P; Huang L; Nie X; Huang S; Guo T; Zhu Y
Mol Cell Proteomics; 2023 Aug; 22(8):100604. PubMed ID: 37353004
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients.
Cavalloni G; Peraldo-Neia C; Massa A; Bergamini C; Trentini A; De Rosa G; Daniele L; Ciccosanti F; Cervellati C; Leone F; Aglietta M
BMC Cancer; 2021 Jul; 21(1):865. PubMed ID: 34320944
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of proteomic components of sera from patients with hepatocellular carcinomas by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time of flying mass spectrometry].
Wang Z; Ruan YB; Guan Y
Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):333-6. PubMed ID: 14514378
[TBL] [Abstract][Full Text] [Related]
19. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
[TBL] [Abstract][Full Text] [Related]
20. Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry.
Seow TK; Ong SE; Liang RC; Ren EC; Chan L; Ou K; Chung MC
Electrophoresis; 2000 May; 21(9):1787-813. PubMed ID: 10870966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]